Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 20,080	$ 13,488
General and administrative	4,538	4,151
Total operating expenses	24,618	17,639
Loss from operations	(24,618)	(17,639)
Other income (expense):
Interest income	1,435	1,120
Other expense:	(3)	(1)
Total other income	1,432	1,119
Net loss	(23,186)	(16,520)
Comprehensive loss:
Net loss	(23,186)	(16,520)
Other comprehensive loss:
Unrealized (loss) gain on securities	(270)	265
Comprehensive loss	$ (23,456)	$ (16,255)
Net loss per share, basic	$ (0.83)	$ (0.67)
Net loss per share, diluted	$ (0.83)	$ (0.67)
Weighted-average shares of common stock outstanding, basic	27,795,827	24,777,847
Weighted-average shares of common stock outstanding, diluted	27,795,827	24,777,847